top of page
Endosane Brings New Hope For Patients With Mental Health Conditions — Founder Interview
This blog post first appeared first on old medium publication (https://medium.com/startuprad-io), and was moved to this blog with the relaunch of our website in summer 2024. What Is This About? Endosane is pioneering a new approach to drug development for mental health conditions, targeting the endocannabinoid system to treat depression, anxiety, and PTSD. The startup brings fresh hope to an area where traditional pharmaceuticals have stagnated for decades. This article is pa
Jörn Menninger
Mar 156 min read
Blue Forest Ventures: Transforming Scientific Research into Marketable Solutions
Executive Summary In this episode, Max Narr, General Partner at Blue Forest Ventures, discusses their strategy of bridging the gap between scientific innovation and investment by translating complex ideas into compelling equity stories. Blue Forest Ventures focuses on deep tech investments with ticket sizes between 500,000 and 1,000,000 euros, excluding heavily regulated fields like drug development. They leverage alternative data sources and AI for market evaluation and emph
Jörn Menninger
Jun 13, 202437 min read
bottom of page